Comparison of the dosage and the possibility of using the individual GLP-1 receptor agonists available on the Polish market as monotherapy, including the trade names of the products_ LAR: a form of long-acting release preparation
| GLP-1 receptor agonist | Dosing frequency | Registration in monotherapy | Trade name of the product |
|---|---|---|---|
| Exenatide LAR | 1 × week | no | Bydureon |
| Dulaglutide | 1 × week | yes | Trulicity |
| Lixisenatide | 1 × day | no | Lyxumia |
| Liraglutide | 1 × day | yes | Victoza |
| Semaglutide | 1 × week | yes | Ozempic |